Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Appili Therapeutics Inc. (APLIF) had Free Cash Flow per Share of $-0.01 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.02M |
|
$-0.77M |
|
-- |
|
$0.02M |
|
$2.12M |
|
$-2.11M |
|
$1.36M |
|
$-0.75M |
|
$-0.75M |
|
$-0.77M |
|
$-0.77M |
|
$-0.77M |
|
$-0.77M |
|
$-2.11M |
|
$-2.11M |
|
123.72M |
|
123.72M |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$1.42M |
|
$0.01M |
|
$0.01M |
|
$1.43M |
|
$13.49M |
|
$0.49M |
|
$0.49M |
|
$13.97M |
|
$-12.54M |
|
$-12.54M |
|
$-12.54M |
|
132.37M |
|
| Cash Flow Statement Financials | |
$-0.97M |
|
-- |
|
$0.11M |
|
$0.89M |
|
$0.03M |
|
$-0.86M |
|
$0.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.11 |
|
-- |
|
-- |
|
-0.04 |
|
-0.75 |
|
100.00% |
|
-11194.47% |
|
-11194.47% |
|
-- |
|
-3962.07% |
|
-4076.44% |
|
$-0.97M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.01 |
|
6238.62 |
|
6.11% |
|
6.11% |
|
-53.70% |
|
6.36% |
|
$-0.09 |
|
|
Free Cash Flow per Share |
$-0.01 |
$-0.01 |
|